Brief: Morphosys AG Subsidiary Constellation Pharmaceuticals Enters Into Global Licensing Agreement With Novartis

Morphosys AG

06/12/2022 21:04

Dec 6 (Reuters) - MorphoSys AG  MORG.DE :
    * FULLY OWNED SUBSIDIARY CONSTELLATION PHARMACEUTICALS, INC.
HAS
ENTERED INTO A GLOBAL LICENSING AGREEMENT WITH NOVARTIS
    * AGREEMENT WITH NOVARTIS INCLUDES RESEARCH, DEVELOP AND
COMMERCIALIZE ITS PRE-CLINICAL INHIBITORS OF A NOVEL CANCER
TARGET
    * MORPHOSYS RECEIVES UPFRONT PAYMENT OF $23 MILLION,
POTENTIAL
MILESTONE PAYMENTS, PLUS MID-SINGLE- TO LOW-DOUBLE-DIGIT
ROYALTIES ON NET SALES

Source text for Eikon:  ID:nEQ8p9CQRa 
Further company coverage:  MORG.DE 
 ((Reuters.Briefs@thomsonreuters.com;))